Steven Bellon

2022

In 2022, Steven Bellon earned a total compensation of $2.1M as Chief Scientific Officer at Foghorn Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$130,500
Option Awards$1,580,167
Salary$435,000
Total$2,145,667

Bellon received $1.6M in option awards, accounting for 74% of the total pay in 2022.

Bellon also received $130.5K in non-equity incentive plan and $435K in salary.

Rankings

In 2022, Steven Bellon's compensation ranked 1,658th out of 5,736 executives tracked by ExecPay. In other words, Bellon earned more than 71.1% of executives.

ClassificationRankingPercentile
All
1,658
out of 5,736
71st
Division
Manufacturing
863
out of 3,125
72nd
Major group
Chemicals And Allied Products
342
out of 1,416
76th
Industry group
Drugs
316
out of 1,317
76th
Industry
Pharmaceutical Preparations
226
out of 963
77th
Source: SEC filing on May 3, 2024.

Bellon's colleagues

We found one more compensation record of an executive who worked with Steven Bellon at Foghorn Therapeutics in 2022.

2022

Adrian Gottschalk

Foghorn Therapeutics

Chief Executive Officer

News

In-depth

You may also like